Onsite reports

Sunday April 23 – Wednesday April 26, 2017

REPORT: Congress Prague highlights

 

Sunday April 23, 2017

VIDEO: Welcome to the 85th EAS Congress

REPORT: Opening Ceremony  & Anitschkow Lecture

 

Monday April 24

VIDEO: Second day of 85th EAS Congress

REPORT: The smoking gun in atherosclerosis– LDL or immune cells?

EAS 2017 INTERVIEW: EAS President Professor Lale Tokgozoglu discusses the cholesterol vs. inflammation debate

EAS 2017 INTERVIEW: Professor Chapman on the new EAS Consensus Panel Statement on LDL causality

EAS 2017 INTERVIEW: Professor Packard discusses implications for primary prevention – LDL causes ASCVD

REPORT: FOURIER up for discussion

EAS 2017 INTERVIEW: Following FOURIER, do we still need ezetimibe in the management of high risk patients?

EAS 2017 INTERVIEW: Can we use imaging to define very high risk patients?

EAS 2017 INTERVIEW: Are very low LDL cholesterol levels safe?

EAS 2017 INTERVIEW: How do the different approaches to PCSK9 inhibition compare?

EAS 2017 INTERVIEW: Identifying the very high risk patient with recurrent events in FOURIER

 

Tuesday April 25

VIDEO: Third day of 85th EAS Congress

REPORT: Plenary focuses on future prospects for management of triglycerides

REPORT: Rare dyslipidemias make the news

REPORT: Keynote Lecture – A salutary lesson from kinetic studies

EAS 2017 INTERVIEW: EAS President Professor Lale Tokgozoglu discusses the role of imaging

 

Wednesday April 26

REPORT: FH News – Update on EAS FH Studies Collaboration, and more…

EAS 2017 INTERVIEW:  Do you see patients with homozygous FH?  

EAS 2017 INTERVIEW: The EAS Consensus Panel Statement on LDL causality in ASCVD: Implications for guidelines 

REPORT: Looking beyond lipids – lifestyle is pivotal